Cited by 118Genetics, Aging, and Longevity in Model OrganismsTelomeres, Telomerase, and SenescenceSirtuins and Resveratrol in Medicine

The road ahead for health and lifespan interventions

Open access
Gonzalez-Freire, Marta, Diaz-Ruiz, Alberto, Hauser, David, Martinez-Romero, Jorge, Ferrucci, Luigi, Bernier, Michel, de Cabo, Rafael·2020·Ageing Research Reviews

Abstract

Aging is a modifiable risk factor for most chronic diseases and an inevitable process in humans. The development of pharmacological interventions aimed at delaying or preventing the onset of chronic conditions and other age-related diseases has been at the forefront of the aging field. Preclinical findings have demonstrated that species, sex and strain confer significant heterogeneity on reaching the desired health- and lifespan-promoting pharmacological responses in model organisms. Translating the safety and efficacy of these interventions to humans and the lack of reliable biomarkers that serve as predictors of health outcomes remain a challenge. Here, we will survey current pharmacological interventions that promote lifespan extension and/or increased healthspan in animals and humans, and review the various anti-aging interventions selected for inclusion in the NIA's Interventions Testing Program as well as the ClinicalTrials.gov database that target aging or age-related diseases in humans.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.arr.2020.101037

Cites

309 of 309 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The energy supply-demand imbalance might be alleviated by interventions including physical activity, calorie restriction, and agents such as metformin, resveratrol, and rapamycin.

    “This imbalance might be alleviated by various interventions, including physical activity, calorie restriction and agents such as metformin, resveratrol and rapamycin10.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

5 of the 314 references couldn’t be matched to a known paper.

Research works printed but not linked: 2

  1. Olshansky SJ, Martin GM, Kirkland JL, 2016 Aging: The Longevity Dividend, ed. Cold Spring Harbor Laboratory Press, New York. 10.1101/cshperspect.a025932. · DOI · Paper page
  2. Qi YDM, Hirsch ML, Cote AM, Lainez EO, Johnson MO, Gagne DJ, Vlasuk GP, Ellis JL, 2010 Activation of Sirtuin1 (SIRT1) by the Novel Small Molecule SRT2104 Promotes Body Weight Loss, Increases Exercise Capacity and Improves Insulin Sensitivity in Diet-induced Obese Mice. ADA, 70th Scientific Sessions, pp. 390 poster.

Cited by

Sorted by citations

Authors
Gonzalez-Freire, M., Diaz-Ruiz, A., Hauser, D., Martinez-Romero, J., Ferrucci, L., Bernier, M., & de Cabo, R.
Affiliations
National Institutes of Health (US)
Venue
Ageing Research Reviews
Publisher
Elsevier BV
Published
2020-05
Volume
59
Pages
101037
ISSN
1568-1637 (ISSN-L)
OpenAlex
W3006812869
Cited by
118
References
314
Citations by year
2026: 7 · 2025: 23 · 2024: 11 · 2023: 10 · 2022: 26 · 2021: 20 · 2020: 20
FWCI
2.39
Type
journal article
Language
en
Open access
Locations
  • Ageing Research Reviews (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • Docusalut (Conselleria de Salut i Consum del Govern de les Illes Balears) (submittedVersion, cc-by-nc-nd)
  • Hispana (submittedVersion, cc-by-nc-nd)
Funders
National Institutes of Health
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
  • Health Sciences › Medicine › Physiology › Telomeres, Telomerase, and Senescence
  • Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
Keywords
anti-aging interventions, lifespan extension, healthspan, pharmacological interventions, age-related diseases, chronic disease prevention, model organisms, sex differences, species differences, biomarkers, clinical trials
MeSH terms
Aging, Animals, Health, Humans, Longevity

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review